Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Sells $158,710.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Jamie Samath also recently made the following trade(s):

• On Wednesday, January 29th, Jamie Samath sold 94 shares of Intuitive Surgical stock. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34.
• On Tuesday, December 10th, Jamie Samath sold 270 shares of Intuitive Surgical stock. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50.
• On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.00, for a total transaction of $101,332.00.
• On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $595.70 on Tuesday. The firm has a market cap of $212.18 billion, a PE ratio of 92.93, a P/E/G ratio of 5.67 and a beta of 1.39. The business’s 50 day simple moving average is $554.85 and its 200 day simple moving average is $514.80. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Institutional Trading of Intuitive Surgical

Hedge funds and other institutional investors have recently made changes to their positions in the business. Livforsakringsbolaget Skandia Omsesidigt increased its position in Intuitive Surgical by 356.7% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,923 shares of the medical equipment provider’s stock worth $1,436,000 after buying an additional 2,283 shares during the last quarter. Valeo Financial Advisors LLC boosted its stake in shares of Intuitive Surgical by 13.2% during the 3rd quarter. Valeo Financial Advisors LLC now owns 4,119 shares of the medical equipment provider’s stock worth $2,023,000 after acquiring an additional 480 shares during the period. Ritholtz Wealth Management increased its holdings in shares of Intuitive Surgical by 14.1% during the 3rd quarter. Ritholtz Wealth Management now owns 4,421 shares of the medical equipment provider’s stock worth $2,172,000 after acquiring an additional 546 shares during the last quarter. Inspire Investing LLC raised its stake in Intuitive Surgical by 2.1% in the 3rd quarter. Inspire Investing LLC now owns 32,718 shares of the medical equipment provider’s stock valued at $16,073,000 after acquiring an additional 667 shares during the period. Finally, Renaissance Investment Group LLC lifted its holdings in Intuitive Surgical by 0.5% during the 3rd quarter. Renaissance Investment Group LLC now owns 30,503 shares of the medical equipment provider’s stock valued at $14,985,000 after purchasing an additional 145 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of analyst reports. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Truist Financial increased their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Finally, Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.